VANNI, IRENE
 Distribuzione geografica
Continente #
EU - Europa 4.487
AS - Asia 675
NA - Nord America 431
SA - Sud America 49
AF - Africa 19
OC - Oceania 1
Totale 5.662
Nazione #
IT - Italia 4.386
US - Stati Uniti d'America 421
SG - Singapore 247
CN - Cina 160
VN - Vietnam 119
BD - Bangladesh 75
FR - Francia 44
BR - Brasile 34
HK - Hong Kong 27
FI - Finlandia 11
JP - Giappone 11
DE - Germania 9
AR - Argentina 7
GB - Regno Unito 7
ID - Indonesia 7
IN - India 5
UZ - Uzbekistan 5
CA - Canada 4
CH - Svizzera 4
EC - Ecuador 4
IE - Irlanda 4
MA - Marocco 4
NL - Olanda 4
PH - Filippine 4
PK - Pakistan 4
PL - Polonia 3
TN - Tunisia 3
ZA - Sudafrica 3
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
IQ - Iraq 2
JM - Giamaica 2
KE - Kenya 2
MX - Messico 2
MY - Malesia 2
RU - Federazione Russa 2
UA - Ucraina 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
CR - Costa Rica 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SE - Svezia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
VE - Venezuela 1
Totale 5.662
Città #
Genova 1.905
Genoa 1.503
Rapallo 524
Vado Ligure 380
San Jose 114
Singapore 112
Ashburn 69
Lauterbourg 39
Council Bluffs 37
Beijing 35
Ho Chi Minh City 33
Hanoi 29
Hong Kong 27
Santa Clara 18
Helsinki 11
Bordighera 10
New York 10
St Louis 10
Rome 9
Tokyo 9
Buffalo 8
Biên Hòa 7
Frankfurt am Main 7
Los Angeles 7
Haiphong 5
Milan 5
Atlanta 4
Dublin 4
Zurich 4
Buenos Aires 3
Catania 3
Chicago 3
Da Nang 3
Guangzhou 3
Houston 3
Hải Dương 3
London 3
Naples 3
Phú Thọ 3
São Paulo 3
Tashkent 3
Warsaw 3
Addis Ababa 2
Alexandria 2
Amsterdam 2
Ancona 2
Baghdad 2
Bari 2
Birmingham 2
Bình Dương 2
Charlotte 2
City of London 2
Dallas 2
Davao City 2
Denver 2
Gravina in Puglia 2
Jersey City 2
Johannesburg 2
Karachi 2
Kingston 2
Kyiv 2
Mexico City 2
Nairobi 2
New Delhi 2
Ninh Bình 2
Orem 2
Paris 2
Petaling Jaya 2
Phoenix 2
Quận Bình Thạnh 2
Rabat 2
Serra 2
Tianjin 2
Acalanes Ridge 1
Ahmedabad 1
Albertville 1
Alta Floresta 1
Anderson 1
Araraquara 1
Asunción 1
Baton Rouge 1
Bački Jarak 1
Belo Horizonte 1
Ben Arous 1
Benton Harbor 1
Billerica 1
Boardman 1
Boston 1
Bragado 1
Bratislava 1
Braço do Norte 1
Brooklyn 1
Brussels 1
Bukhara 1
Bình Phước 1
Bắc Ninh 1
Cabot 1
Cairo 1
Can Tho 1
Caracas 1
Totale 5.063
Nome #
Twenty years of molecular analyses in amyotrophic lateral sclerosis: genetic landscape of Italian patients 208
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer:18F-FDG PET/CT study 198
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients 197
Efficacy of motesanib diphosphate in non-small-cell lung cancer. 186
Belagenpumatucel-L for the treatment of non-small cell lung cancer 176
Next Generation Sequencing In Non-Small Cell Lung Cancer: New Avenues Toward The Personalized Medicine. 168
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma 167
Current State of Target Treatment in BRAF Mutated Melanoma 154
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 153
Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system 152
Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalin 148
Oral vinorelbine in the treatment of non-small-cell lung cancer. 147
Next-generation sequencing workflow for NSCLC critical samples using a targeted sequencing approach by ion torrent PGM™ platform 139
Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients 138
Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors 138
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 134
An improved method for HLA-B and -C supratyping 134
Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typing. 133
Afatinib for the treatment of non-small cell lung cancer 131
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer 131
Human leukocyte antigen-B (-Bw6/-Bw4 I 80, T 80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis 130
Exosomes: a new horizon in lung cancer 128
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control 126
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy 122
Whole-genome sequencing as standard practice for the analysis of clonality in outbreaks of meticillin-resistant Staphylococcus aureus in a paediatric setting 118
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 112
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer 112
Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: Report of a secondary anaplastic astrocytoma carrying the IDH1 mutation 111
Understanding the checkpoint blockade in lung cancer immunotherapy 111
Vinflunine for the treatment of non-small cell lung cancer 103
Development and validation of a multiplex quantitative polymerase chain reaction assay for the detection of Mollicutes impurities in human cells, cultured under good manufacturing practice conditions, and following European Pharmacopoeia requirements and the International Conference on Harmonization guidelines 102
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab 100
Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer 96
Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients 96
Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples 95
Prognostic and therapeutic implications of microRNA in malignant pleural mesothelioma 90
Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments 90
A sensible technique to detect mollicutes impurities in human cells cultured in GMP condition 89
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma 88
A NEXT GENERATION SEQUENCING APPROACH TO GENOMIC LANDSCAPE IN MELANOMA PATIENTS: EVOLUTION OF PATIENT-SPECIFIC RESPONSE TO THERAPY 87
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape 81
Molecular Assessment in Patients with Melanoma: When and Why? 74
Troubleshooting fine-tuning procedures for qPCR system design 74
Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome 71
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 71
Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms 66
Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy” 62
Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report 49
Totale 5.786
Categoria #
all - tutte 23.641
article - articoli 22.997
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 328
Totale 46.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/2022522 66 11 17 39 23 33 11 133 17 66 16 90
2022/2023605 51 57 8 49 100 99 2 42 100 8 87 2
2023/2024335 8 40 14 42 22 49 11 38 18 15 8 70
2024/20251.049 25 63 34 57 142 91 142 182 61 59 96 97
2025/20261.787 257 25 110 93 245 133 255 73 170 182 143 101
Totale 5.786